First Trust Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $919K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $464K | Sell |
|
|||||
|
2024
Q3 | $1.27M | Sell |
|
|||||
|
2024
Q2 | $2.88M | Buy |
|
|||||
|
2024
Q1 | $2.93M | Buy |
|
|||||
|
2023
Q4 | $459K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.91M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $292K | Buy |
|
|||||
|
2022
Q2 | $268K | Sell |
|
|||||
|
2022
Q1 | $1.8M | Sell |
|
|||||
|
2021
Q4 | $3.93M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $10.3M | Sell |
|
|||||
|
2015
Q4 | $116M | Buy |
|
|||||
|
2015
Q3 | $50.7M | Buy |
|
|||||
|
2015
Q2 | $110M | Sell |
|
|||||
|
2015
Q1 | $132M | Buy |
|